A small tool to view real-world ActivityPub objects as JSON! Enter a URL
or username from Mastodon or a similar service below, and we'll send a
request with
the right
Accept
header
to the server to view the underlying object.
{
"@context": [
"https://www.w3.org/ns/activitystreams",
{
"ostatus": "http://ostatus.org#",
"atomUri": "ostatus:atomUri",
"inReplyToAtomUri": "ostatus:inReplyToAtomUri",
"conversation": "ostatus:conversation",
"sensitive": "as:sensitive",
"toot": "http://joinmastodon.org/ns#",
"votersCount": "toot:votersCount",
"blurhash": "toot:blurhash",
"focalPoint": {
"@container": "@list",
"@id": "toot:focalPoint"
},
"Hashtag": "as:Hashtag"
}
],
"id": "https://respublicae.eu/users/EMA_News/statuses/108527645254265440",
"type": "Note",
"summary": null,
"inReplyTo": null,
"published": "2022-06-23T16:07:26Z",
"url": "https://respublicae.eu/@EMA_News/108527645254265440",
"attributedTo": "https://respublicae.eu/users/EMA_News",
"to": [
"https://www.w3.org/ns/activitystreams#Public"
],
"cc": [
"https://respublicae.eu/users/EMA_News/followers"
],
"sensitive": false,
"atomUri": "https://respublicae.eu/users/EMA_News/statuses/108527645254265440",
"inReplyToAtomUri": null,
"conversation": "tag:respublicae.eu,2022-06-23:objectId=566210:objectType=Conversation",
"content": "<p>💉 EMA has recommended the use of Novavax’s <a href=\"https://respublicae.eu/tags/COVID19vaccine\" class=\"mention hashtag\" rel=\"tag\">#<span>COVID19vaccine</span></a>, Nuvaxovid, in adolescents aged 12 to 17 years. </p><p><a href=\"https://respublicae.eu/tags/PandemicResponse\" class=\"mention hashtag\" rel=\"tag\">#<span>PandemicResponse</span></a> <a href=\"https://respublicae.eu/tags/PublicHealth\" class=\"mention hashtag\" rel=\"tag\">#<span>PublicHealth</span></a> <a href=\"https://respublicae.eu/tags/VaccinesWork\" class=\"mention hashtag\" rel=\"tag\">#<span>VaccinesWork</span></a> </p><p>👉 <a href=\"https://www.ema.europa.eu/en/news/ema-recommends-authorisation-nuvaxovid-adolescents-aged-12-17\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><span class=\"invisible\">https://www.</span><span class=\"ellipsis\">ema.europa.eu/en/news/ema-reco</span><span class=\"invisible\">mmends-authorisation-nuvaxovid-adolescents-aged-12-17</span></a> </p><p> 🐦🔗: <a href=\"https://nitter.eu/EMA_News/status/1539978306669449218\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><span class=\"invisible\">https://</span><span class=\"ellipsis\">nitter.eu/EMA_News/status/1539</span><span class=\"invisible\">978306669449218</span></a></p>",
"contentMap": {
"en": "<p>💉 EMA has recommended the use of Novavax’s <a href=\"https://respublicae.eu/tags/COVID19vaccine\" class=\"mention hashtag\" rel=\"tag\">#<span>COVID19vaccine</span></a>, Nuvaxovid, in adolescents aged 12 to 17 years. </p><p><a href=\"https://respublicae.eu/tags/PandemicResponse\" class=\"mention hashtag\" rel=\"tag\">#<span>PandemicResponse</span></a> <a href=\"https://respublicae.eu/tags/PublicHealth\" class=\"mention hashtag\" rel=\"tag\">#<span>PublicHealth</span></a> <a href=\"https://respublicae.eu/tags/VaccinesWork\" class=\"mention hashtag\" rel=\"tag\">#<span>VaccinesWork</span></a> </p><p>👉 <a href=\"https://www.ema.europa.eu/en/news/ema-recommends-authorisation-nuvaxovid-adolescents-aged-12-17\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><span class=\"invisible\">https://www.</span><span class=\"ellipsis\">ema.europa.eu/en/news/ema-reco</span><span class=\"invisible\">mmends-authorisation-nuvaxovid-adolescents-aged-12-17</span></a> </p><p> 🐦🔗: <a href=\"https://nitter.eu/EMA_News/status/1539978306669449218\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><span class=\"invisible\">https://</span><span class=\"ellipsis\">nitter.eu/EMA_News/status/1539</span><span class=\"invisible\">978306669449218</span></a></p>"
},
"attachment": [
{
"type": "Document",
"mediaType": "image/jpeg",
"url": "https://files.respublicae.eu/media_attachments/files/108/527/645/169/020/238/original/7e2b60a773ee4c80.jpeg",
"name": null,
"blurhash": "UBMb77RQqaMyD*vgDj$*2c4pJk%0FyJ.tlRP",
"width": 1200,
"height": 675
}
],
"tag": [
{
"type": "Hashtag",
"href": "https://respublicae.eu/tags/COVID19vaccine",
"name": "#COVID19vaccine"
},
{
"type": "Hashtag",
"href": "https://respublicae.eu/tags/PandemicResponse",
"name": "#PandemicResponse"
},
{
"type": "Hashtag",
"href": "https://respublicae.eu/tags/publichealth",
"name": "#publichealth"
},
{
"type": "Hashtag",
"href": "https://respublicae.eu/tags/VaccinesWork",
"name": "#VaccinesWork"
}
],
"replies": {
"id": "https://respublicae.eu/users/EMA_News/statuses/108527645254265440/replies",
"type": "Collection",
"first": {
"type": "CollectionPage",
"next": "https://respublicae.eu/users/EMA_News/statuses/108527645254265440/replies?only_other_accounts=true&page=true",
"partOf": "https://respublicae.eu/users/EMA_News/statuses/108527645254265440/replies",
"items": []
}
}
}